Recce eyes US Defence grants with early data for R327 on burn wounds
Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MLA | Ann: Removal from Official List (COB 30/11/2017) | 30/11/17 | 0 | 886 | |||
|
|||||||
MLA | Ann: IMPLEMENTATION OF SCHEME OF ARRANGEMENT | 30/11/17 | 0 | 1.0K | |||
|
|||||||
MLA | Ann: LODGMENT OF COURT ORDERS WITH ASIC | 20/11/17 | 0 | 597 | |||
|
|||||||
MLA | Ann: Suspension from Official Quotation (COB 20/11/2017) | 20/11/17 | 0 | 661 | |||
|
|||||||
MLA | Ann: Appendix 4C - quarterly | 18/11/17 | 10 | 4.1K | |||
|
|||||||
MLA | Ann: MLA SHAREHOLDERS APPROVE SCHEME | 17/11/17 | 0 | 582 | |||
|
|||||||
MLA | Ann: COURT APPROVES SCHEME OF ARRANGEMENT | 17/11/17 | 0 | 729 | |||
|
|||||||
MLA | Ann: Substituted annexure to announcement re Scheme Meeting | 15/11/17 | 0 | 662 | |||
|
See All Discussions